Target Species
Dogs and cats.
Indications for use
Nandrolone is a testosterone derivative which can be used in the supportive management of chronic renal failure.
Contraindications
Laurabolin should not be used in pregnant animals.
Do not use in animals with hypercalcaemia.
Do not use in animals with androgenic dependent tumours.
Do not use in cases of hypersensitivity to the active substance or to any of the excipients.
Special warnings for each target species
To be used with caution in known cases of hepatic impairment.
Special precautions for use
None.
Operator warnings
In the event of accidental self-injection, transient painful, local reactions may occur. Avoid accidental self-injection. In the case of accidental self-injection, seek medical advice and show the package leaflet or the label to the physician.
This product contains benzyl alcohol and can cause skin irritation. Avoid contact with skin. In the case of contact with skin, wash with soap and water. If irritation persists, seek medical advice. Wash hands after use.
The product can cause eye irritation. Avoid contact with eyes. If the product comes into contact with the eyes, rinse the eyes immediately with plenty of water and seek medical attention if irritation persists.
Virilisation of the foetus may occur if pregnant women are exposed to the product. Therefore, the veterinary medicinal product should not be administered by pregnant women or women trying to conceive.
People with known hypersensitivity to nandrolone or any of the excipients should avoid contact with the veterinary medicinal product.
Adverse Reactions
Long-term use can lead to a change in behavior in very rare cases. This is reversible after stopping treatment. Androgenic side effects can be observed in animals treated with the veterinary medicinal product, in particularly in female animals, in very rare cases.
The frequency of adverse reactions is defined using the following convention:
- very common (more than 1 in 10 animals displaying adverse reactions during the course of one treatment)
- common (more than 1 but less than 10 animals in 100 animals)
- uncommon (more than 1 but less than 10 animals in 1,000 animals)
- rare (more than 1 but less than 10 animals in 10,000 animals)
- very rare (less than 1 animal in 10,000 animals, including isolated reports).
Use during pregnancy or lactation
Laurabolin is contra-indicated in pregnant animals.
Interactions
There is no information on the concurrent use with anticoagulants in dogs. In humans anabolic steroids may potentiate the effects of anticoagulants.
Steroids are known to alter insulin sensitivity. Diabetic animals should be monitored carefully and insulin dose adjustment might be necessary.
Amounts to be administered and administration route
Species Dosage
Dog 2-5 mg/kg
Cat 2-5 mg/kg
As with all hormone therapy there can be considerable variation in response to treatment; the above dosages may need to be adjusted according to clinical response. Treatment may be repeated every 21 days.
Administer by subcutaneous or intramuscular injection, observing usual aseptic precautions.
Swab the septum before removing each dose. Use a dry sterile needle and syringe and avoid introduction of contamination.
Further information:
The product may be used to continue treatment initiated with similarly acting oral preparations. Such preparations may also be used to continue therapy commenced with this product to allow more rapid termination of treatment if necessary.
Overdose
No specific treatment or antidote recommended.
Withdrawal periods
Not applicable.